Thrombophilia, left ventricular dysfunction and intracardiac thrombi in children

Ibrahim Abu-Kishk1, Shaul Baram, Eran Kozer

  • 1Pediatric Division, Assaf Harofeh Medical Center, Zerifin, Israel, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Korean Circulation Journal
|September 28, 2011
PubMed

Insights

Children with cardiac failure and left ventricular dysfunction are at risk for intracardiac thrombi (ICT), particularly those with a hypercoagulable state. Early evaluation for hypercoagulability is crucial in these pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Hematology
  • Critical Care Medicine

Background:

  • Intracardiac thrombi (ICT) are rare in children, but incidence is rising.
  • Left ventricular dysfunction and hypercoagulable states are potential contributors to ICT formation.
  • This study investigates ICT incidence and risk factors in pediatric cardiac failure.

Purpose of the Study:

  • To determine the incidence of intracardiac thrombi (ICT) in children with cardiac failure and left ventricular dysfunction.
  • To identify risk factors for developing ICT upon admission in this pediatric population.
  • To highlight the association between hypercoagulable states and ICT in pediatric cardiac failure.

Main Methods:

  • Retrospective chart review of pediatric patients (up to 18 years) admitted to the Pediatric Intensive Care Unit.
  • Inclusion criteria: cardiac failure with left ventricular dysfunction between 2003-2008.
  • Data collection focused on clinical signs, echocardiographic findings, and history of hypercoagulable states.

Main Results:

  • Twenty-one patients were included, with dilated cardiomyopathy in 52% and myocarditis in others.
  • A history of hypercoagulable states was present in 90% of patients.
  • Patients with a hypercoagulable state had a significantly higher incidence of ICT (3/7) compared to those without (0/12, p=0.043).
  • Two patients with ICT experienced embolic events.

Conclusions:

  • Cardiac failure with left ventricular dysfunction increases ICT risk, especially with coexisting hypercoagulable states.
  • Hypercoagulable states are a significant risk factor for ICT and thromboembolism in pediatric cardiac failure.
  • Thorough evaluation for hypercoagulability on admission is essential for managing these high-risk pediatric patients.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...